Get started
Author

Olivia Pocha

Observed names: O.O. Pocha, Olivia O. Pocha
Institution: Tulane University
Observed institution: Tulane University
ORCID: 0009-0000-8302-382X
Observed ORCID: 0009-0000-8302-382X
OpenAlex ID: A5013787869
Prediction of Resistance to 177 Lu-PSMA Therapy by Assessment of Baseline Circulating Tumor DNA Biomarkers
2023 · Oliver Sartor, Elisa Ledet, et al. · Journal of Nuclear Medicine · 31
PDF
Comparison of circulating tumor DNA between African American and Caucasian patients with metastatic castrate‐resistant prostate cancer post‐abiraterone and/or enzalutamide
2023 · Albert Jang, Sree M. Lanka, et al. · The Prostate · 6
PDF
Evaluation of ctDNA in patients treated with lutetium-177-PSMA-617.
2023 · Sree M Lanka, Albert Jang, et al. · Journal of Clinical Oncology · 1
Genomic alterations in patients with prostate cancer with liver metastases.
2023 · Crystal Casado, Sydney Caputo, et al. · Journal of Clinical Oncology · 1
PDF
Analysis of TP53 gain of function mutations in metastatic castration-resistant prostate cancer.
2023 · Patrick L Sweeney, Sree M Lanka, et al. · Journal of Clinical Oncology · 1
Characterization of Laboratory Eligibility Criteria in Phase III Oncology Trials: A Meta-Epidemiologic Analysis
2026 · Olivia O. Pocha, Avital M. Miller, et al. · JCO oncology advances.
Post-Treatment ctDNA Alterations as Predictors of Response to 177Lu-PSMA in Metastatic Castration-Resistant Prostate Cancer
2025 · O.A. Akerele, O.O. Pocha, et al. · International Journal of Radiation Oncology*Biology*Physics
Radiating Knowledge: Evaluating the Educational Impact of a Virtual Introductory Lecture on Radiation Oncology at Medical Schools Without Departments
2025 · Anthony Alanis, Stephanie Dudzinski, et al. · International Journal of Radiation Oncology*Biology*Physics
ctDNA characterization in mCRPC patients with pathogenic germline variants.
2025 · Tivoli Nguyen, Nicholas Habibian, et al. · Journal of Clinical Oncology
PDF
Evaluation of ctDNA alterations in lethal mCRPC.
2025 · Minqi Huang, Nicholas Habibian, et al. · Journal of Clinical Oncology
PDF
68Ga-PSMA-11 patients with newly diagnosed and recurrent prostate cancer (Firefly Study): Preliminary results.
2023 · Charlotte Hawkins, Olivia Pocha, et al. · Journal of Clinical Oncology
PDF
Characterization of ctDNA findings at the end of life in patients with prostate cancer.
2023 · Kanika Gupta, Sydney Caputo, et al. · Journal of Clinical Oncology
Comparison of ctDNA between African American and Caucasian patients with CRPC post abiraterone and/or enzalutamide.
2023 · Albert Jang, Minqi Huang, et al. · Journal of Clinical Oncology
Evaluation of ctDNA in patients with CRPC with pathogenic germline mutations in BRCA2.
2023 · Minqi Huang, Ellen B. Jaeger, et al. · Journal of Clinical Oncology
PDF
Works count: 14
Citation count: 40
H-index: 2
I10-index: 1
Year
Topic
Type